Results
13
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
13 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
540737 | ₹837.65 | 21.2% | 22.1% | ₹10.8b | n/a | PE38.6x | n/a | 0% | ||
SATKARTAR | ₹227.70 | 49.1% | n/a | ₹3.6b | n/a | PE56.9x | n/a | n/a | ||
500420 | ₹3,115.70 | -7.3% | 17.7% | ₹1.1t | ₹3,639.83 | PE56.6x | E23.3% | 0.9% | ||
NATCOPHARM | ₹1,283.60 | 9.6% | 49.4% | ₹229.9b | ₹1,349.17 | PE11.8x | E-19.1% | 0.4% | ||
JAGSNPHARM | ₹250.96 | 4.1% | 109.4% | ₹16.7b | n/a | PE31.8x | n/a | 0.8% | ||
500488 | ₹27,784.65 | 9.1% | -3.3% | ₹590.4b | ₹29,052.86 | PE46x | E11.3% | 1.5% | ||
524632 | ₹228.65 | -0.1% | 511.6% | ₹10.0b | n/a | PE69.4x | n/a | 0.4% | ||
INDSWFTLAB | ₹103.75 | -2.3% | -10.0% | ₹6.1b | n/a | PE1.6x | n/a | n/a | ||
JSLL | ₹1,940.90 | 1.6% | 161.7% | ₹48.3b | n/a | PE57.3x | n/a | 0.2% | ||
524212 | ₹228.10 | 5.5% | 42.9% | ₹7.5b | n/a | PE14.1x | n/a | n/a | ||
539561 | ₹4.17 | -10.9% | -81.9% | ₹1.7b | n/a | PE7x | n/a | n/a | ||
531569 | ₹332.85 | 2.0% | 89.4% | ₹4.0b | n/a | PE57.2x | n/a | n/a | ||
BETA | ₹1,929.95 | 1.0% | 39.9% | ₹18.6b | n/a | PE45.3x | n/a | n/a |